Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-22T17:44:56.992Z Has data issue: false hasContentIssue false

Urinary excretion of catechin metabolites by human subjects after red wine consumption

Published online by Cambridge University Press:  09 March 2007

Jennifer L. Donovan*
Affiliation:
Departments of Viticulture and Enology, University of California, Davis, California 95616, USA
Sidika Kasim-Karakas
Affiliation:
Endocrinology and Metabolism andUniversity of California, Davis, California 95616, USA
J. Bruce German
Affiliation:
Food Science and Technology, University of California, Davis, California 95616, USA
Andrew L. Waterhouse
Affiliation:
Departments of Viticulture and Enology, University of California, Davis, California 95616, USA
*
*Corresponding author: Dr Jennifer L. Donovan, present address Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry, Room 246N, Medical University of South Carolina, 67 President Street, Charleston, SC 29425, USA, fax +1 843 792 6318, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Little is known about flavonoid metabolism and excretion in man. In the present study, the urinary excretion of a major flavonoid in wine, catechin, and its metabolites, were measured after nine human subjects each consumed 120 ml red wine (RW) on one day and de-alcoholized red wine (DRW) on a separate day. Both the RW and DRW contained 120 (SEM 3) ΜMOL CATECHIN (35 MG). GC–MS ANALYSES OF THE TRIMETHYLSILYLATED DERIVATIVES OF CATECHIN AND 3″ AND 4″ METHYLCATECHIN WERE PERFORMED BEFORE AND AFTER HYDROLYSIS OF CONJUGATES BY Β-GLUCURONIDASE AND SULFATASE. BASELINE URINE SAMPLES COLLECTED PRIOR TO WINE CONSUMPTION CONTAINED 0·013 (sem 0·005) μmol catechin and metabolites. During the 8 h period following consumption of RW and DRW, 6·6 (sem 0·9) and 5·3 (sem 0·6) μmol catechin and metabolites were excreted in 893 (sem 94) and 740 (sem 101) ml urine respectively. This corresponded to 3·0–10·3 % of the dose after RW and 2·1–8·2 % of the dose after DRW. The amount of catechin and metabolites excreted in urine was 20 % higher after RW compared with DRW (P=0·06). Catechin in all urine samples was present as metabolites and there were no differences in the proportions of individual metabolites after RW and DRW. As with other flavonoids, the fate of most ingested catechin is not yet known.

Type
Research Article
Copyright
Copyright © The Nutrition Society 2002

References

Ameer, B, Weintraub, RA, Johnson, JV, Yost, RA & Rouseff, L (1996) Flavanone absorption after naringin, hesperidin, and citrus administration. Clinical Pharmacology and Therapeutics 60, 3440.CrossRefGoogle ScholarPubMed
Arts, ICW, Hollman, PCH, Feskins, EJM, de Mesquita, HBB & Kromhout, D (2001) Catechin intake and associated dietary and lifestyle factors in a representative sample of Dutch men and women. European Journal of Clinical Nutrition 55, 7681.CrossRefGoogle Scholar
Arts, ICW, van de Putte, B & Hollman, PCH (2000) Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. Journal of Agricultural and Food Chemistry 48, 17521757.CrossRefGoogle ScholarPubMed
Arts, ICW, van de Putte, B & Hollman, PCH (2000) Catechin contents of foods commonly consumed in The Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. Journal of Agricultural and Food Chemistry 48, 17461751.CrossRefGoogle ScholarPubMed
Bell, JRC, Donovan, JL, Wong, R, Waterhouse, AL, German, JB, Walzem, RL & Kasim-Karakas, SE (2000) (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. American Journal of Clinical Nutrition 71, 103108.CrossRefGoogle ScholarPubMed
Cao, G, Sofic, E & Prior, RL (1996) Antioxidant capacity of tea and common vegetables. Journal of Agricultural and Food Chemistry 44, 34263431.CrossRefGoogle Scholar
Clifford, AJ, Ebeler, S, Ebeler, JD, Bill, ND, Hinrichs, SH, Teissedre, P-L & Waterhouse, AL (1996) Delayed tumor onset in transgenic mice fed an amino-acid diet supplemented with red wine solids. American Journal of Clinical Nutrition 64, 748756.CrossRefGoogle ScholarPubMed
Criqui, MH & Ringel, BL (1994) Does diet or alcohol explain the French paradox? Lancet 344, 17191723.CrossRefGoogle ScholarPubMed
Das, NP (1971) Studies on flavonoid metabolism and absorption and metabolism of (+)-catechin in man. Biochemical Pharmacology 20, 34353445.CrossRefGoogle ScholarPubMed
Das, NP & Sothy, SP (1971) Studies on flavonoid metabolism: biliary and urinary excretion of metabolites of (+)-[U-14C] catechin. Biochemical Journal 125, 417423.CrossRefGoogle Scholar
Da Silva, EL, Piskula, M & Terao, J (1998) Enhancement of antioxidative ability of rat plasma by oral administration of (-)-epicatechin. Free Radical Biology and Medicine 24, 12091216.CrossRefGoogle ScholarPubMed
Day, A, Bao, Y, Morgan, M & Williamson, G (2000) Conjugation position of quercetin glucuronides and effect on biological activity. Free Radical Biology and Medicine 29, 12341243.CrossRefGoogle ScholarPubMed
Demrow, HS & Folts, JD (1994) Gastric or IV administration of French red wine but not white wine inhibits in vivo platelet activity and thromobosis in stenosed canine coronary arteries. Journal of the American College of Cardiology 49A, Special Issue.Google Scholar
Demrow, HS, Slane, PR & Folts, JD (1995) Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 91, 11821188.CrossRefGoogle ScholarPubMed
de Pascual-Teresa, S, Santos-Buelga, C & Rivas-Gonzalo, JC (2000) Quantitative analysis of flavan-3-ols in spanish foodstuffs and beverages. Journal of Agricultural and Food Chemistry 48, 53315337.CrossRefGoogle ScholarPubMed
Déprez, S, Brézillon, C, Rabot, S, Philippe, C, Mila, I, Lapierre, C & Scalbert, A (2000) Metabolism of polymeric proanthocyanidins by a human colonic microflora. Journal of Nutrition 130, 27332738.CrossRefGoogle ScholarPubMed
de Vries, JHM, Jeanne, HH, Hollman, PCH, Meyboom, S, Busyman, MNCP, Zock, PL, van Staveren, WA & Katan, MB (1998) Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. American Journal of Clinical Nutrition 68, 6065.CrossRefGoogle ScholarPubMed
de Vries, JHM, Hollman, PCH, van Amersfoort, I, Olthof, MR & Katan, MB (2001) Red wine is a poor source of bioavailable flavonols in men. Journal of Nutrition 131, 745748.CrossRefGoogle ScholarPubMed
de Whalley, CV, Rankin, SM, Hoult, JRS, Jessup, W & Leake, DS (1990) Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochemical Pharmacology 39, 17431750.CrossRefGoogle ScholarPubMed
Donovan, JL, Bell, JR, Kasim-Karakas, S, German, JB, Walzem, RL, Hansen, RJ & Waterhouse, AL (1999 a) Catechin is present as metabolites in human plasma after consumption of red wine. Journal of Nutrition 129, 16621668.CrossRefGoogle ScholarPubMed
Donovan, JL, Luthria, DL, Stremple, P & Waterhouse, AL (1999 b) Analysis of (+)-catechin, (-)-epicatechin and their 3′ and 4′ O-methylated analogs: A comparison of sensitive methods. Journal of Chromatography B 726, 277283.CrossRefGoogle ScholarPubMed
Fitzpatrick, DF, Hirschfield, SL & Coffey, RG (1993) Endothelium-dependent vasorelaxing activity of wine and other grape products. American Journal of Physiology 265, H774H778.Google ScholarPubMed
Fuhr, U & Kummert, AL (1995) The fate of naringin in humans: A key to grapefruit juice–drug interactions. Clinical Pharmacology and Therapeutics 58, 365373.CrossRefGoogle ScholarPubMed
Fuhrman, B, Lavy, A & Aviram, M (1995) Consumption of red wine with meals reduces the susceptibility of human plasma and low density lipoprotein to lipid peroxidation. American Journal of Clinical Nutrition 61, 549554.CrossRefGoogle ScholarPubMed
Grønbæk, M, Deis, A, Sorensen, TIA, Becker, U, Schnohr, P & Jensen, G (1995) Mortality associated with moderate intakes of wine, beer and spirits. British Medical Journal 310, 11651169.CrossRefGoogle ScholarPubMed
Gugler, R, Leschik, M & Dengler, HJ (1975) Disposition of quercetin in man after single oral and intravenous doses. European Journal of Clinical Pharmacology 9, 229234.CrossRefGoogle ScholarPubMed
Hackett, AM, Griffiths, LA, Broillet, A & Wermeille, M (1983) The metabolism and excretion of (+)-[14C]cyanidanol-3 in man following oral administration. Xenobiotica 13, 279283.CrossRefGoogle Scholar
Hayek, T, Fuhrman, B, Vaya, J, Rosenblat, M, Belinky, P, Coleman, R, Elis, A & Aviram, M (1997) Reduced progression of atherosclerosis in apolipopritein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arteriosclerosis Thrombosis and Vascular Biology 17, 27442752.CrossRefGoogle ScholarPubMed
Hertog, MGL, Feskens, EJM, Hollman, PCH, Katan, JB & Kromhout, D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet 342, 10071011.CrossRefGoogle ScholarPubMed
Hertog, MGL, Kromhout, D, Aravanis, C & Blackburn, H et al. (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Archives of Internal Medicine 155, 381386.CrossRefGoogle ScholarPubMed
Hollman, PCH & Arts, ICW (2000) Flavonols, flavones, and flavanols – nature, occurrence and dietary burden. Journal of the Science of Food and Agriculture 80, 10811093.3.0.CO;2-G>CrossRefGoogle Scholar
Hollman, PCH, de Vries, JHM, van Leeuwen, SD, Mengelers, MJB & Katan, MB (1995) Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. American Journal of Clinical Nutrition 62, 12761282.CrossRefGoogle ScholarPubMed
Hollman, PCH, Trijp, J, Mengelers, MJB, Vries, JHM & Katan, MB (1997) Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Letters 114, 139140.CrossRefGoogle ScholarPubMed
Klatsky, AL & Armstrong, MA (1993) Alcoholic beverage choice and risk of coronary artery disease mortality: Do red wine drinkers fare best? American Journal of Cardiology 71, 467469.CrossRefGoogle ScholarPubMed
Kühnau, J (1976) The flavonoids, a class of semi-essential food components: their role in human nutrition. World Review of Nutrition and Dietetics 24, 117191.CrossRefGoogle ScholarPubMed
Lapidot, T, Harel, S, Granit, R & Kanner, J (1998) Bioavailability of red wine anthocyanins as detected in human urine. Journal of Agricultural and Food Chemistry 46, 42974302.CrossRefGoogle Scholar
Lee, MJ, Wang, ZY, Li, H, Chen, L, Sun, Y, Gobbo, S, Balentine, DA & Yang, CS (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiology Biomarkers and Prevention 4, 393399.Google ScholarPubMed
Li, C, Lee, M-J, Sheng, S, Meng, X, Prabhu, S, Winnik, B, Huang, B, Chung, JY, Yan, S, Ho, C-T & Yang, CS (2000) Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chemical Research in Toxicology 13, 177184.CrossRefGoogle ScholarPubMed
Manach, C, Morand, C, Crespy, V, Demigne, C, Texier, O, Regerat, F & Remesy, C (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Letters 426, 331336.CrossRefGoogle ScholarPubMed
Meselhy, MR, Nakamura, N & Hattori, M (1997) Biotransformation of (-)-epicatechin 3-O-gallate by human intestinal bacteria. Chemical and Pharmaceutical Bulletin 45, 888893.CrossRefGoogle ScholarPubMed
Nidgikar, SV, Williams, NR, Griffin, BA & Howard, AN (1998) Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. American Journal of Clinical Nutrition 68, 258265.Google Scholar
Nielsen, SE, Kall, M, Justesen, U, Schou, A & Dragsted, LO (1997) Human absorption and excretion of flavonoids after broccoli consumption. Cancer Letters 114, 173174.CrossRefGoogle ScholarPubMed
Nielsen, SE, Young, JF, Daneshvar, B, Lauridsen, ST, Knuthsen, P, Sandstrom, B & Dragsted, LO (1999) Effect of parsley intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in humans. British Journal of Nutrition 81, 447455.CrossRefGoogle Scholar
Osman, HE, Maaleg, N, Shanmuganayagum, D & Folts, JD (1998) Grape juice but not orange or grapefruit juice inhibits platelet activity in dogs and monkeys (Macaca fasciularis). Journal of Nutrition 128, 23072312.CrossRefGoogle Scholar
Pace-Asciak, CR, Rounova, O, Hahn, SE, Diamandis, EP & Goldberg, DM (1996) Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clinica Chimica Acta 246, 163182.CrossRefGoogle ScholarPubMed
Plumb, GW, de Pascual-Teresa, S, Santos-Buelga, C, Cheynier, V & Williamson, G (1998) Antioxidant properties of catechins and proanthocyanidins: effect of polymerisation, galloylation and glycosylation. Free Radical Research 29, 351358.CrossRefGoogle ScholarPubMed
Rein, D, Lotito, S, Holt, R, Keen, C, Schmitz, H & Fraga, C (2000 a) Epicatechin in human plasma: In vivo determination and effect of chocolate consumption on plasma oxidation status. Journal of Nutrition 130S, 2109S2114S.CrossRefGoogle Scholar
Rein, D, Paglieroni, TG, Pearson, DA, Wun, T, Schmitz, HH, Gosselin, R & Keen, CL (2000 b) Cocoa and wine polyphenols modulate platelet activation and function. Journal of Nutrition 130S, 2120S2126S.CrossRefGoogle Scholar
Renaud, S & De Lorgeril, M (1992) Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 339, 15231526.CrossRefGoogle ScholarPubMed
Renaud, S & Ruf, J-C (1996) Effects of alcohol on platelet functions. Clinica Chimica Acta 246, 7789.CrossRefGoogle ScholarPubMed
Richelle, M, Tavazzi, I, Enslen, M & Offord, EA (1999) Plasma kinetics in man of epicatechin from black chocolate. European Journal of Clinical Nutrition 53, 2226.CrossRefGoogle ScholarPubMed
Ritchey, JG & Waterhouse, AL (1999) A standard red wine: monomeric phenolic analysis of commercial Cabernet Sauvignon wines. American Journal of Enology and Viticulture 50, 91100.CrossRefGoogle Scholar
Rozman, KK & Klaassen, CD (1996) Absorption, distribution and excretion of toxicants. In Casarett & Doull's Toxicology: The Basic Science of Poisons, pp. 91112 [Klaasen, KK, editor]. New York, NY: McGraw-Hill.Google Scholar
Ruf, JC, Berger, JL & Renaud, S (1995) Platelet rebound effect of alcohol withdrawl and wine drinking in rats. Arteriosclerosis Thrombosis and Vascular Biology 15, 140144.CrossRefGoogle Scholar
Scalbert, A & Williamson, G (2000) Dietary intake and bioavailability of polyphenols. Journal of Nutrition 130S, 2073S2085S.CrossRefGoogle Scholar
St Leger, AS, Cochrane, AL & Moore, F (1979) Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 10171020 May 12.CrossRefGoogle Scholar
Sasaki, S & Kesteloot, H (1994) Wine and non-wine alcohol: differential effect on all-cause and cause-specific mortality. Nutrition, Metabolism, and Cardiovascular Diseases 4, 177182.Google Scholar
Schramm, DD, Pearson, DA & German, JB (1997) Endothelial cell basal PGI2 release is stimulated by wine in vitro: one mechanism that may mediate the vasoprotective effects of wine. Nutritional Biochemistry 8, 647651.CrossRefGoogle Scholar
Schramm, DD, Wang, JF, Holt, RR, Ensunsa, JL, Gonsalves, JL, Lazarus, SA, Schmitz, HH, German, JB & Keen, CL (2001) Chocolate procyanidins decrease the leukotriene–prostacyclin ratio in humans and human aortic endothelial cells. American Journal of Clinical Nutrition 73, 3640.CrossRefGoogle ScholarPubMed
Seigneur, M, Bonnet, J, Dorian, B, Benchimol, D, Drouillet, F, Gouverneur, G, Larrue, J, Crockett, R, Boisseau, M, Ribereau-Gayon, P & Bricaud, H (1990) Effect of the consumption of alcohol, white wine, and red wine on platelet function and serum lipids. Journal of Applied Cardiology 5, 215222.Google Scholar
Serafini, M, Ghiselli, A & Ferro-Luzzi, A (1996) In vivo antioxidant effect of green and black tea in man. European Journal of Clinical Nutrition 50, 2832.Google ScholarPubMed
Serafini, M, Maiani, G & Ferro-Luzzo, A (1998) Alcohol-free red wine enhances plasma antioxidant capacity in humans. Journal of Nutrition 128, 10031007.CrossRefGoogle ScholarPubMed
Shaw, IC & Griffiths, LA (1980) Identification of the major biliary metabolite of (+)-catechin in the rat. Xenobiotica 10, 905911.CrossRefGoogle ScholarPubMed
Shaw, IC, Hackett, AM & Griffiths, LA (1982) Metabolism and excretion of the liver-protective agent (+)-catechin in experimental hepatitis. Xenobiotica 12, 405416.CrossRefGoogle ScholarPubMed
So, FV, Guthrie, N, Chambers, AF, Moussa, M & Carroll, KK (1996) Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutrition and Cancer 26, 167181.CrossRefGoogle ScholarPubMed
Teissedre, PL, Frankel, EN, Waterhouse, AL, Peleg, H & German, JB (1996) Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wine. Journal of the Science of Food and Agriculture 90, 5561.3.0.CO;2-X>CrossRefGoogle Scholar
Walle, T, Eaton, EA & Walle, UK (1995) Quercetin, a potent and specific inhibitor of the human P-form phenolsulfotransferase. Biochemical Pharmacology 50, 731734.CrossRefGoogle Scholar
Watanabe, S, Yamaguchi, M, Sobue, T, Takahashi, T, Miura, T, Arai, Y, Mazur, W, Wahala, K & Aldercreutz, H (1998) Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (Kinako). Journal of Nutrition 128, 17101715.CrossRefGoogle ScholarPubMed
Wermeille, M, Turin, E & Griffiths, LA (1983) Identification of the major urinary metabolites of (+)-catechin and 3-O-methyl-(+)-catechin in man. European Journal of Drug Metabolism and Pharmacokinetics 8, 7784.CrossRefGoogle ScholarPubMed
Whitehead, TP, Robinson, D, Allaway, S, Syms, J & Hale, A (1995) Effect of red wine ingestion on the antioxidant capacity of serum. Clinical Chemistry 41, 3235.CrossRefGoogle ScholarPubMed
Xu, X, Harris, KS, Wang, H-J, Murphy, PA & Hendrich, S (1995) Bioavailability of soybean isoflavones depends upon gut microflora in women. Journal of Nutrition 125, 23072315.CrossRefGoogle ScholarPubMed
Xu, X, Wang, H-J, Murphy, PA, Cook, L & Hendrich, S (1994) Daidzein is a more bioavailable soymilk isoflavone than is genestein in adult women. Journal of Nutrition 124, 825832.CrossRefGoogle ScholarPubMed
Xu, R, Yokoyama, WH, Irving, D, Rein, D, Walzem, RL & German, JB (1998) Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters. Atherosclerosis 137, 2936.CrossRefGoogle ScholarPubMed
Young, JF, Dragsted, LO, Daneshvar, B, Lauridsen, ST, Hansen, M & Sandstrom, B (2000) The effect of grape-skin extract on oxidative status. British Journal of Nutrition 84, 505513.CrossRefGoogle ScholarPubMed
Young, JF, Nielsen, SE, Haraldsdottir, J, Daneshvar, B, Lauridsen, ST, Knuthsen, P, Crozier, A, Sandstrom, B & Dragsted, LO (1999) Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. American Journal of Clinical Nutrition 69, 8794.CrossRefGoogle ScholarPubMed